Diffinity Genomics
Chiral Technologies Acquiring Diffinity Genomics
DNA purification firm Diffinity will become a business unit of Chiral following the completion of the deal.
Cepheid disclosed in a filing with the US Securities and Exchange Commission this week that it has terminated the employment of Nicolaas Arnold, its executive vice president of worldwide commercial operations.
People In The News: Jan 11, 2013
NEW YORK (GenomeWeb News) – AssureRx Health, a neuropsychiatric personalized medicine company, has formed a scientific advisory board, which will guide the company's R&D efforts on pharmacogenomic products.
Diffinity Genomics this month won a pair of grants worth a total of $700,000 from the National Institutes of Health to support the company's ongoing development of new technologies and products for rapid nucleic acid purification using specialized pipette tips.
In Brief This Week: Roche NimbleGen; Life Technologies; PerkinElmer; Luminex; CLC bio; Diffinity Genomics; Vela Diagnostics; Bayer CropScience
NEW YORK (GenomeWeb News) – Roche will shutter its NimbleGen microarray business, and will phase out array production and services by the end of the year.
Jun 7, 2012
Dec 1, 2011
Mar 2, 2011
People in the News: Mar 2, 2011
Premium
Nov 11, 2010
Jun 17, 2010